Stay updated with breaking news from Krish Krishnan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Thank you for standing by and welcome to the Krystal Biotech Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are on a lesson-only mode.
Operator: Thank you for standing by and welcome to the Krystal Biotech Third Quarter 2023 Earnings Conference Call. As a reminder today’s conference call is being recorded.
Cantor Fitzgerald said it expects a “very strong product launch” of a gene therapy made by Krystal Biotech, the topical gel Vyjuvek which treats a rare skin disease.
PITTSBURGH, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company fo...
By Denny Jacob Krystal Biotech shares tumbled 10% to $111.67 following a wider loss in its latest quarter. The stock is up 42% on the year. The...